Get started
Award

602646

Funder: FP7 Health
Funded outputs count: 8
Funder award ID: 602646
OpenAlex ID: G1912263256
Asymptomatic carriers of the p.A53T SNCA mutation: Data from the PPMI study
2022 · Athina Maria Simitsi, Christos Koros, et al. · Parkinsonism & Related Disorders · 3
PDF
A double-hit in vivo model of GBA viral microRNA-mediated downregulation and human alpha-synuclein overexpression demonstrates nigrostriatal degeneration
2022 · Alexia Polissidis, Effrosyni Koronaiou, et al. · Neurobiology of Disease · 9
Serum uric acid and total bilirubin as putative biomarkers of resistance in Prodromal Parkinson’s disease: Longitudinal data from the PPMI study
2021 · Christos Koros, Athina-Maria Simitsi, et al. · medRxiv
PDF
Apathy: An underestimated feature in GBA and LRRK2 non-manifesting mutation carriers
2021 · Ioanna Pachi, Christos Koros, et al. · Parkinsonism & Related Disorders · 14
PDF
Psychosis‐Like Behavior and Hyperdopaminergic Dysregulation in Human α‐Synuclein BAC Transgenic Rats
2020 · Alexia Polissidis, Maria Koronaiou, et al. · Movement Disorders · 29
Autoimmune hemolytic anemia, demyelinating relapse, and AQP1 antibodies after alemtuzumab infusion
2020 · John S. Tzartos, Serena Valsami, et al. · Neurology Neuroimmunology & Neuroinflammation · 10
PDF
High-salt diet does not boost neuroinflammation and neurodegeneration in a model of α-synucleinopathy
2020 · Antonio Heras-Garvin, Violetta Refolo, et al. · Journal of Neuroinflammation · 20
PDF
Anle138b modulates α‐synuclein oligomerization and prevents motor decline and neurodegeneration in a mouse model of multiple system atrophy
2018 · Antonio Heras‐Garvin, Daniel Weckbecker, et al. · Movement Disorders · 123
PDF